-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OTT-166 in Proliferative Diabetic Retinopathy (PDR)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OTT-166 in Proliferative Diabetic Retinopathy (PDR) Drug Details: SF-0166 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Brincidofovir in Adenoviridae Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brincidofovir in Adenoviridae Infections Drug Details: Brincidofovir (Tembexa) is an alkoxyalkyl ester prodrug containing the synthetic,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Brincidofovir in Polyomavirus Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brincidofovir in Polyomavirus Infections Drug Details: Brincidofovir (Tembexa) is an alkoxyalkyl ester prodrug containing the synthetic,...
-
Product Insights
![]()
Profbud – Symbio City Live & Invest Residential Complex – Masovian Voivodeship
Equip yourself with the essential tools needed to make informed and profitable decisions with our Profbud - Symbio City Live & Invest Residential Complex - Masovian Voivodeship report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
![]()
Fonterra Co-operative Group Ltd – Company Profile
Fonterra Co-operative Group Ltd (Nutiani) is a manufacturer and marketer of dairy products. The company provides powdered and flavored milk, ready-to-drink milk, yogurts, iced coffee, cheeses, spreads, butter, ice cream, everyday nutrition powders, culinary creams, bakery butter, and advanced nutrition products to various consumers and foodservice providers. Fonterra markets its products under various brands including Anlene, Anchor, Perfect Italiano, Mammoth, De Winkel, Kapiti, Fresh ‘n Fruity, Primo, Symbio, and Mainland brands, to mention a few. It operates and manages various...
Add to Basket -
Company Profile
![]()
SymBio Pharmaceuticals Ltd – Company Profile
SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. The company's pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chronic lymphocytic leukemia (CLL), rigosertib (SyB L-1101), a novel tumor specific kinase inhibitor targeting hematologic malignancies and solid tumors, and Brincidofovir (SyB V-1901) for effective treatment against a wide spectrum of infectious diseases caused by DNA viruses, including herpes viruses (including...
Add to Basket -
Company Profile
![]()
Chimerix Inc – Company Profile
Chimerix Inc (Chimerix) is a biopharmaceutical company. It develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s pipeline product portfolio includes ONC201, ONC206, ONC212, CMX521 drug candidates. Its products are used to treat various diseases like gliomas, central nervous system tumors, SARS-CoV-2 (COVID-19), and IND-enabling studies. Its brincidofovir tablet and oral suspension formulations are used in the treatment of smallpox disease in adult and pediatric patients. The company markets its products under the brand name of TEMBEXA. The...
Add to Basket -
Product Insights
![]()
Bioabsorbable Stents (BAS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
BAS Pipeline Products Market Report Overview Bioabsorbable stents are also known as bio-re-absorbable or biodegradable coronary stents. They are made from the material found in dissolvable sutures known as polylactic acid. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents. One unit refers to one bioabsorbable stent system. The BAS pipeline market research...
-
Product Insights
![]()
Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Coronary Stents Pipeline Market Report Overview A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – brincidofovir
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry brincidofovir Drug Details Brincidofovir (Tembexa) is an alkoxyalkyl ester prodrug containing the synthetic, acyclic nucleoside...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.